Literature DB >> 2523228

Noradrenaline attenuates the natriuretic effect of atrial natriuretic factor in man.

J J McMurray1, P H Seidelin, R A Brown, A D Struthers.   

Abstract

1. The effects of noradrenaline (0.025 micrograms kg-1 min-1) and atrial natriuretic factor (0.04 micrograms kg-1 min-1) alone, and in combination, were studied in eight healthy salt replete men. 2. Atrial natriuretic factor increased urinary sodium excretion and flow rate without changing glomerular filtration rate or systemic haemodynamics. 3. Noradrenaline decreased urinary sodium excretion without changing glomerular filtration rate, urinary flow rate or systemic haemodynamics. 4. When atrial natriuretic factor was administered against a background infusion of noradrenaline the natriuretic response to the peptide was significantly attenuated. 5. Further analysis showed that this attenuation was due to the additive antinatriuretic effect of noradrenaline rather than to a specific interaction between atrial natriuretic factor and noradrenaline. 6. The possible significance of this interplay between noradrenaline and atrial natriuretic factor is discussed in the context of experimental evidence for an important role of the sympathetic nervous system in modulating the renal effects of atrial natriuretic factor in animals.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2523228      PMCID: PMC1379698          DOI: 10.1111/j.1365-2125.1989.tb05328.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  22 in total

1.  Inhibition of sympathoadrenal activity by atrial natriuretic factor in dogs.

Authors:  J Holtz; O Sommer; E Bassenge
Journal:  Hypertension       Date:  1987-04       Impact factor: 10.190

2.  The effect of 6-hydroxydopamine on the renal responses to atrial natriuretic extract and blood volume expansion.

Authors:  S Hathaway; S Solomon
Journal:  Proc West Pharmacol Soc       Date:  1984

3.  Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure.

Authors:  T B Levine; G S Francis; S R Goldsmith; A B Simon; J N Cohn
Journal:  Am J Cardiol       Date:  1982-05       Impact factor: 2.778

Review 4.  Neurogenic regulation of renal tubular sodium reabsorption.

Authors:  G F DiBona
Journal:  Am J Physiol       Date:  1977-08

5.  Novel double-isotope technique for enzymatic assay of catecholamines, permitting high precision, sensitivity and plasma sample capacity.

Authors:  M J Brown; D A Jenner
Journal:  Clin Sci (Lond)       Date:  1981-11       Impact factor: 6.124

Review 6.  An emerging relationship between peripheral sympathetic nervous activity and atrial natriuretic factor.

Authors:  O Kuchel; W Debinski; K Racz; N T Buu; R Garcia; J R Cusson; P Larochelle; M Cantin; J Genest
Journal:  Life Sci       Date:  1987-04-20       Impact factor: 5.037

7.  Attenuation of reflex forearm vasoconstriction by alpha-human atrial natriuretic peptide in men.

Authors:  A Takeshita; T Imaizumi; N Nakamura; H Higashi; T Sasaki; M Nakamura; K Kangawa; H Matsuo
Journal:  Circ Res       Date:  1987-10       Impact factor: 17.367

8.  Radio-immunoassay for plasma alpha human atrial natriuretic peptide: a comparison of direct and pre-extracted methods.

Authors:  A M Richards; G Tonolo; G D McIntyre; B J Leckie; J I Robertson
Journal:  J Hypertens       Date:  1987-04       Impact factor: 4.844

9.  Blunted natriuresis to atrial natriuretic peptide in chronic sodium-retaining disorders.

Authors:  J P Koepke; G F DiBona
Journal:  Am J Physiol       Date:  1987-05

10.  Activation of vagal depressor reflexes by atriopeptins inhibits renal sympathetic nerve activity.

Authors:  P Thorén; A L Mark; D A Morgan; T P O'Neill; P Needleman; M J Brody
Journal:  Am J Physiol       Date:  1986-12
View more
  3 in total

1.  DOPA decarboxylase inhibition does not influence the diuretic and natriuretic response to exogenous alpha-atrial natriuretic peptide in man.

Authors:  S Kageyama; J Brown; R Causon; M O'Flynn; V Aber
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Renal effects of xamoterol in patients with moderate heart failure.

Authors:  H E Bøtker; H K Jensen; L R Krusell; E V Sørensen
Journal:  Cardiovasc Drugs Ther       Date:  1993-02       Impact factor: 3.727

Review 3.  Interactions between atrial natriuretic factor and the autonomic nervous system.

Authors:  C C Lang; A D Struthers
Journal:  Clin Auton Res       Date:  1991-12       Impact factor: 4.435

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.